Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Brain Behav Immun. 2021 Feb 9;94:266–273. doi: 10.1016/j.bbi.2021.01.033

Table 3.

Summary of Chemokines Studies in Serum/Plasma of MDD Patients.

Study / Year Chemokines Findings
Song et al. (1998) CXCL8 Increased
Simon el al. (2008) CXCL8, CCL2, CCL3, CCL11 Increased
Sutcigil et al. (2007) CCL2 Increased
O’Brien et al. (2007) CXCL8 No significant difference
Eller et al. (2008) CXCL8 No significant difference
Wang et al. (2008) CXCL10 Increased
Musselman et al. (2000) OC3CL1, CLL3 Increased
Lehto et al. (2010) CCL2, CCL3 Decreased
Oglodek et al. (2014) CXCL12, CCL5 Increased
Meta-analyses
Eyre et al. (2016) CCL Increased
CXCL8 No significant difference
Leighton et al. (2018) CCL2, CCL3, CCL11, CXCL7, CXCL8 Increased
CCL4 Decreased
CCL5 No significant difference